Presentation is loading. Please wait.

Presentation is loading. Please wait.

Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?  Andrew W. ElBardissi, MD, MPH, Daniel.

Published byMarcia Walton Modified over 5 years ago

Similar presentations

Presentation on theme: "Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?  Andrew W. ElBardissi, MD, MPH, Daniel."— Presentation transcript:

1 Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?  Andrew W. ElBardissi, MD, MPH, Daniel J. DiBardino, MD, Frederick Y. Chen, MD, PhD, Michael H. Yamashita, MD, Lawrence H. Cohn, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 139, Issue 5, Pages (May 2010) DOI: /j.jtcvs Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

2 Figure 1 Study power versus total sample size based on study parameters. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

3 Figure 2 Cumulative incidence analysis (composite of stroke, TIA, and peripheral thromboemboli). TE, Thromboembolism. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

4 Figure 3 Long-term survival using the Cox proportional hazard approximation. ASA, Acetylsalicylic acid; NYHA, New York Heart Association. The Journal of Thoracic and Cardiovascular Surgery  , DOI: ( /j.jtcvs ) Copyright © 2010 The American Association for Thoracic Surgery Terms and Conditions

Download ppt "Is early antithrombotic therapy necessary in patients with bioprosthetic aortic valves in normal sinus rhythm?  Andrew W. ElBardissi, MD, MPH, Daniel."

Similar presentations

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,

Tubular heart valves: A new tissue prosthesis design—Preclinical evaluation of the 3F aortic bioprosthesis James L. Cox, MD, Niv Ad, MD, Keith Myers, BS,
Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 

Max B. Mitchell, MD  The Journal of Thoracic and Cardiovascular Surgery 
Of mice and men and surgical transcatheter aortic valve insertion

Of mice and men and surgical transcatheter aortic valve insertion
Manuel J. Antunes, MD, PhD, DSc 

Manuel J. Antunes, MD, PhD, DSc 
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.

Aborted episode of sudden death due to delayed heart block after transcatheter aortic valve insertion  Kevin L. Greason, MD, Paul A. Friedman, MD, Daniel.
Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,

Reoperative minimal access aortic valve surgery: Minimal mediastinal dissection and minimal injury risk  Minoru Tabata, MD, MPH, Zain Khalpey, MD, PhD,
Mitral stenosis with pulmonary hypertension: We should operate early

Mitral stenosis with pulmonary hypertension: We should operate early
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D

Puja Gaur, MD, Tsuyoshi Kaneko, MD, Siobhan McGurk, BS, James D
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 

Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Form ever follows function

Form ever follows function
Victor van Berkel, MD, PhD 

Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 

William M. DeCampli, MD, PhD 
Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.

Functional mitral stenosis after mitral valve repair is a true anatomic problem that originates from the time of surgery  Vincent Chan, MD, MPH, Thierry.
Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent?  Giuseppe Santarpino, MD, Steffen.

Early degeneration of the St Jude Medical Trifecta bioprosthetic aortic valve: A problem of the leaflets or of the stent?  Giuseppe Santarpino, MD, Steffen.
Bicuspid aortic valve aortopathy: One size fits all?

Bicuspid aortic valve aortopathy: One size fits all?
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 

Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation  Michael H. Kwon,

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation  Michael H. Kwon,
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,

Similar presentations

Ads by Google